World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
14519
World Ranking
4387
National Ranking
1991

Julio Aliberti publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Julio Aliberti sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 108 publications — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Julio Aliberti D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Julio Aliberti sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 48 D-Index — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Julio Aliberti is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research spans multiple areas within medicine, immunology, and microbiology, with a focus on infectious diseases, immune cell function, and host-pathogen interactions.

The scientist's main fields of study include:

  • Medicine
  • Immunology and Microbiology

Their subfields of study cover:

  • Epidemiology
  • Public Health, Environmental and Occupational Health
  • Immunology
  • Parasitology
  • Virology

Aliberti's work has concentrated on specific topics such as:

  • Cytomegalovirus and herpesvirus research
  • Malaria Research and Control
  • Complement system in diseases
  • Mosquito-borne diseases and control
  • Toxoplasma gondii Research Studies
  • Herpesvirus Infections and Treatments
  • Immune Cell Function and Interaction

Their publication record includes articles in several scientific journals, such as:

  • Frontiers in Immunology
  • OPAL (Open@LaTrobe) (La Trobe University)
  • PLoS neglected tropical diseases

Some notable recent papers authored or coauthored by Aliberti include:

  • "Platelet disturbances correlate with endothelial cell activation in uncomplicated Plasmodium vivax malaria," published in 2020 in PLoS neglected tropical diseases
  • "C5aR1 Activation Drives Early IFN-γ Production to Control Experimental Toxoplasma gondii Infection," published in 2020 in Frontiers in Immunology
  • "Editorial: CCR5: A receptor at the center stage in infection," published in 2022 in Frontiers in Immunology
  • "All patients vs. patients included in the multiplex-based assay," published in 2020 in OPAL (Open@LaTrobe) (La Trobe University)
  • "Primers and probes for qPCR," published in 2020 in OPAL (Open@LaTrobe) (La Trobe University)

Frequent coauthors collaborating with Aliberti include:

  • João Luiz Silva-Filho
  • Carla C. Judice
  • Ana Carolina Andrade Vitor Kayano
  • Ricardo Khouri
  • Diógenes S. de Lima

Best Publications

  • Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.

    Steffen Jung;Julio Aliberti;Petra Graemmel;Mary Jean Sunshine

  • Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

    Makoto Arita;Francesca Bianchini;Julio Aliberti;Alan Sher

  • T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells

    Andre A. Lighvani;David M. Frucht;Dragana Jankovic;Hidehiro Yamane

  • CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal.

    Oliver Schulz;Alexander D Edwards;Marco Schito;Julio Aliberti

  • Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.

    Charles A. Scanga;Julio Aliberti;Dragana Jankovic;Florence Tilloy

  • CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells.

    J Aliberti;C Reis e Sousa;M Schito;S Hieny

  • Essential role for ICSBP in the in vivo development of murine CD8α+ dendritic cells

    Julio Aliberti;Oliver Schulz;Oliver Schulz;Daniel J. Pennington;Daniel J. Pennington;Hideki Tsujimura;Hideki Tsujimura

  • Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent.

    Fabiana S Machado;James E Johndrow;Lisia Esper;Alexandra Dias

  • Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages.

    J. S. Silva;G. N. R. Vespa;M. A. G. Cardoso;J. C. S. Aliberti

  • Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes.

    J C Aliberti;M A Cardoso;G A Martins;R T Gazzinelli

  • Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity.

    J Aliberti;S Hieny;C Reis e Sousa;C N Serhan

  • Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity

    Fabiana Simão Machado;Gislâine Aparecida Martins;Júlio César Soares Aliberti;Fabiola Leslie Antunes Cardoso Mestriner

  • Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production.

    Andre Bafica;Charles A. Scanga;Charles Serhan;Fabiana Machado

  • Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells

    Julio Aliberti;Jesus G. Valenzuela;Vern B. Carruthers;Sara Hieny

  • Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-γ as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi.

    André Talvani;André Talvani;Cristiana S Ribeiro;Júlio C.S Aliberti;Vladimir Michailowsky

  • Hemophagocytosis causes a consumptive anemia of inflammation

    Erin E. Zoller;Jennifer E. Lykens;Catherine E. Terrell;Julio Aliberti

  • Parasite-induced Lipoxin A4 Is an Endogenous Regulator of IL-12 Production and Immunopathology in Toxoplasma gondii Infection

    Julio Aliberti;Charles Serhan;Alan Sher

  • Cutting Edge: Dendritic Cells Are Essential for In Vivo IL-12 Production and Development of Resistance against Toxoplasma gondii Infection in Mice

    Cheng-Hu Liu;Yu-ting Fan;Alexandra Dias;Lisia Esper

  • Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology.

    Caetano Reis e Sousa;George Yap;Oliver Schulz;Neil Rogers

  • β-Chemokines Enhance Parasite Uptake and Promote Nitric Oxide-Dependent Microbiostatic Activity in Murine Inflammatory Macrophages Infected with Trypanosoma cruzi

    Júlio C. S. Aliberti;Fabiana S. Machado;Janeusa T. Souto;Ana P. Campanelli

Frequent Co-Authors

Alan Sher
Alan Sher National Institute of Allergy and Infectious Diseases
João S. Silva
João S. Silva Universidade de São Paulo
Ricardo T. Gazzinelli
Ricardo T. Gazzinelli Universidade Federal de Minas Gerais
Charles N. Serhan
Charles N. Serhan Brigham and Women's Hospital
Caetano Reis e Sousa
Caetano Reis e Sousa The Francis Crick Institute
John F. Andersen
John F. Andersen National Institutes of Health
Hana Golding
Hana Golding US Food and Drug Administration
Mauro M. Teixeira
Mauro M. Teixeira Universidade Federal de Minas Gerais
Dragana Jankovic
Dragana Jankovic National Institute of Allergy and Infectious Diseases
Fernando Q. Cunha
Fernando Q. Cunha Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of healthcare and research careers. For those interested in clinical roles, exploring online absn programs for non nurses can be an excellent way to transition into nursing without a prior nursing background. These accelerated programs are designed to build foundational skills quickly, which is crucial for entering the healthcare workforce.

If you are looking for programs with more accessible admission criteria, consider options like the easiest accelerated nursing programs or the easiest lpn programs to get into. These pathways often provide a smoother and faster entry into nursing professions, allowing students to gain hands-on experience sooner.

For advanced practice roles, it’s important to research what is the easiest np program to find pathways that balance rigorous training with flexible learning. Nurse practitioners with immunology knowledge play a critical role in managing immune-related diseases, making immunology-focused education highly valuable.

Overall, the integration of immunology with nursing education enhances career opportunities and patient care, making these related online degrees worth considering for a rewarding healthcare career.

Best Scientists Citing Julio Aliberti

Trending Scientists

Recently Published Articles